Status:
COMPLETED
Sexual Health Impact of Using Pre-exposure HIV Prophylaxis
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Pre-exposure HIV Prophylaxis (PrEP)
Eligibility:
MALE
18+ years
Brief Summary
Epidemiological and psychosociological survey of people on pre-exposure HIV prophylaxis (PrEP).
Detailed Description
This study is perform to study the sexual health satisfaction of men who have sex with men (MSM), since the use pre-exposure HIV prophylaxis (PrEP), compared to the time before PrEP.
Eligibility Criteria
Inclusion
- Adult patient, male having sex with men, not infected with HIV, and using HIV prophylaxis by pre-exposure treatment (PrEP) for at least 1 year, received in consultation for renewal of this prescription.
- Able to give his non-opposition to participate in the research.
- Affiliation to a social security scheme.
Exclusion
- Patient under curatorship/guardianship or safeguard of justice
- Refusal to participate
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 12 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05269199
Start Date
April 1 2022
End Date
March 12 2023
Last Update
May 1 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Brioude
Brioude, France
2
CEGIDD Clermont Ferrand
Clermont-Ferrand, France
3
CHU Clermont-Ferrand
Clermont-Ferrand, France
4
CH Le Puy en Velay
Le Puy-en-Velay, France